Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
Pharmaceutics · 20.11.2024 · 16 (11) · 1486
DOI: 10.3390/pharmaceutics16111486 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.11.2024. Verfasst von Katarina Vrbnjak und 1 weiteren Autor:innen. Beteiligte Einrichtung: VIB-KU Leuven Center for Cancer Biology (VIB), 3000 Leuven, Belgium. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: stichting tegen kanker, RNS, Stichting tegen Kanker.
Abstract (Originalsprache)
Recent technological advancements, including computer-assisted drug discovery, gene-editing techniques, and high-throughput screening approaches, have greatly expanded the palette of methods for the discovery of peptides available to researchers. These emerging strategies, driven by recent advances in bioinformatics and multi-omics, have significantly improved the efficiency of peptide drug discovery when compared with traditional in vitro and in vivo methods, cutting costs and improving their reliability. An added benefit of peptide-based drugs is the ability to precisely target protein–protein interactions, which are normally a particularly challenging aspect of drug discovery. Another recent breakthrough in this field is targeted protein degradation through proteolysis-targeting chimeras. These revolutionary compounds represent a noteworthy advancement over traditional small-molecule inhibitors due to their unique mechanism of action, which allows for the degradation of specific proteins with unprecedented specificity. The inclusion of a peptide as a protein-of-interest-targeting moiety allows for improved versatility and the possibility of targeting otherwise undruggable proteins. In this review, we discuss various novel wet-lab and computational multi-omic methods for peptide drug discovery, provide an overview of therapeutic agents discovered through these cutting-edge techniques, and discuss the potential for the therapeutic delivery of peptide-based drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VIB-KU Leuven Center for Cancer Biology (VIB), 3000 Leuven, Belgium.
ORCID-Profile: Katarina Vrbnjak, Raj Nayan Sewduth
Förderung
- stichting tegen kanker
- RNS, Stichting tegen Kanker
Zitieren
APA
Vrbnjak, K., & Sewduth, R. N. (2024). Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation. Pharmaceutics, 16(11), 1486. https://doi.org/10.3390/pharmaceutics16111486
Vancouver
Vrbnjak K, Sewduth RN. Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation. Pharmaceutics. 2024;16(11):1486. doi:10.3390/pharmaceutics16111486
BibTeX
@article{Vrbnjak2024,
author = {Vrbnjak, Katarina and Sewduth, Raj Nayan},
title = {Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {11},
pages = {1486},
doi = {10.3390/pharmaceutics16111486}
}
EUVIMED